Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of NK cell antigen specific effector activity by modulation of CXCR6 (CD186)

Modulation of NK cell antigen specific effector activity by modulation of CXCR6 (CD186)

US Patent 9872905 · Granted Jan 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Delivery of biomolecules to immune cells2025
Vaccine nanotechnology2023
Delivery of biomolecules to immune cells2021
Vaccine nanotechnology2020
Amphiphile-polymer particles2020
Microvessel endothelial cell surface markers and uses thereof2019
Venule endothelial cell genes and uses thereof2019
Vaccines comprising bisphosphonate and methods of use thereof2019
Vaccine nanotechnology2017
Vaccine nanotechnology2016
Vaccine nanotechnology2016
Adjuvant incorporation in immunoanotherapeutics2016